Eco Science Solutions (ESSI) 10-Q 15 Sep 14 2015 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Jul. 31, 2014	Sep. 15, 2014
Document and Entity Information:	'	'
Entity Registrant Name	'Eco Science Solutions, Inc.	'
Document Type	'10-Q	'
Document Period End Date	31-Jul-14	'
Amendment Flag	'false	'
Entity Central Index Key	'0001490873	'
Current Fiscal Year End Date	'--01-31	'
Entity Common Stock, Shares Outstanding	'	28,893,001
Entity Filer Category	'Smaller Reporting Company	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Well-known Seasoned Issuer	'No	'
Document Fiscal Year Focus	'2015	'
Document Fiscal Period Focus	'Q2	'

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Jul. 31, 2014	Jan. 31, 2014
Balance Sheets	'	'
Cash and cash equivalents	$2,149	$5,684
Total current assets	2,149	5,684
TOTAL ASSETS	2,149	5,684
Accounts payable and accrued expenses	30,787	37,856
Related party payable	58,250	58,250
Related party loans	22,000	'
Notes payable-convertible	240,550	'
Total current liabilities	351,587	96,106
Related party loans	'	22,000
Notes payable-convertible	'	250,000
Related party loans-convertible	69,569	16,991
Total long-term iabilities	69,569	288,991
Total liabilities	421,156	385,097
Preferred stock, $.001 par, 50,000,000 shares authorized, non and 2,500,000 issued and outstanding at July 31, 2014 and January 31, 2014, respectively	'	2,500
Common stock, $0.10 par, 650,000,000 shares authorized, 28,893,001 and 443,001 issued and outstanding at July 31, 2014 and January 31, 2014, respectively	2,889,300	44,300
Additional paid in capital-preferred	'	5,262,500
Additional paid in capital-common	5,216,078	2,203,828
Accumulated deficit	-8,524,385	-7,892,541
Total stockholders' deficit	-419,007	-379,413
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$2,149	$5,684

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets - Parenthetical (Unaudited) (USD $)	Jul. 31, 2014	Jan. 31, 2014
Statement of Financial Position	'	'
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	2,500,000
Preferred stock, shares outstanding	0	2,500,000
Common Stock, par value	$0.10	$0.10
Common Stock, shares authorized	650,000,000	650,000,000
Common Stock, shares issued	28,893,001	443,001
Common Stock, shares outstanding	28,893,001	443,001

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended		56 Months Ended
	Jul. 31, 2014	Jul. 31, 2013	Jul. 31, 2014	Jul. 31, 2013	Jul. 31, 2014
Statement of Operations	'	'	'	'	'
Revenue	'	'	'	'	'
Cost of sales	'	'	'	'	'
Gross Profit	'	'	'	'	'
General and administrative expenses	16,390	18,000	40,607	36,000	159,770
Net operating loss	-16,390	-18,000	-40,607	-36,000	-159,770
Interest expense	-4,605	-3,781	-8,737	-7,439	-24,988
Amortization of stock options/stock compensation	-211,250	-222,083	-582,500	-444,166	-2,888,750
Gain on foreign currency exchange	'	'	'	'	783
Impairment loss	'	'	'	'	-5,265,000
Total other income (expenses)	-215,855	-225,864	-591,237	-451,605	-8,177,955
Net loss from continuing operations	-232,245	-243,864	-631,844	-487,605	-8,337,725
Net loss from discontinued operations	'	-111,124	'	-223,249	-780,211
Net loss	($232,245)	($354,988)	($631,844)	($710,854)	($9,117,936)
Continuing operations	($0.01)	($0.55)	($0.03)	($1.10)	'
Discontinued operations	'	($0.25)	'	($0.50)	'
Weighted average common shares outstanding - basic and diluted	28,831,044	443,001	18,680,017	443,001	'

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended		56 Months Ended
	Jul. 31, 2014	Jul. 31, 2013	Jul. 31, 2014
Statement of Cash Flows	'	'	'
Net loss	($631,844)	($710,854)	($9,117,936)
Net loss from discontinued operations	'	-223,249	-780,211
Net loss from continuing operations	-631,844	-487,605	-8,337,725
Amortization of stock options/stock compensation	582,500	444,166	2,888,750
Impairment loss	'	'	5,265,000
Increase (decrease) in accounts payable and accrued expenses	-8,483	7,439	29,374
Increase in related party payables	1,414	32,000	59,664
Net cash used in operating activities	-56,413	-4,000	-94,937
Proceeds from related party loans	52,578	'	91,569
Proceeds from notes payable	'	'	250,000
Subscriptions received	300	'	300
Net cash provided by financing activities	52,878	0	341,869
Net cash provided by continuing operations	-3,535	-4,000	246,932
Net cash used in operating activities	'	-97,650	-284,645
Net cash used in investing activities	'	-21,837	-40,113
Net cash provided by (used in) financing activities	'	-133,455	79,975
Net cash used in discontinued operations	'	-252,942	-244,783
Net increase (decrease) in cash	-3,535	-256,942	2,149
Cash - beginning of period	5,684	287,421	'
Cash - end of period	2,149	30,479	2,149
Recapitalization due to share exchange	'	'	-108,622
Preferred stock issued for patent license	'	'	5,265,000
Conversion of preferred stock to common stock	5,265,000	'	5,265,000
Conversion of debt to common stock	9,450	'	9,450
Distribution of assets upon spin off	'	'	-15,013
Distribution of liabilities upon spin off	'	'	608,564
Subscriptions receivable	-300	'	-300
Interest paid	'	'	'
Income taxes paid	'	'	'

Nature_of_Business_and_Continu

Nature of Business and Continuance of Operations	6 Months Ended
	Jul. 31, 2014
Notes	'
Nature of Business and Continuance of Operations	'
	NOTE 1: Nature of Business and Continuance of Operations
	The Company was incorporated in the state of Nevada on December 8, 2009 under the name Pristine Solutions, Inc. The Company’s wholly owned subsidiary, Pristine Solutions Limited, was incorporated under the laws of Jamaica. The Company’s original business plan focused on developing a network of sales points for the sale and service of tankless water heaters in Jamaica, through Pristine Solutions Limited.
	On August 22, 2012, Christine Buchanan-McKenzie resigned from all positions with the Company, including, but not limited to that of President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer, and a member of the Board of Directors.  The resignation did not involve any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. On the same day, Mr. Michael Borkowski was appointed as President, Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer, and a member of the Board of Directors of the Company.
	On August 23, 2012, the Company and its controlling stockholders entered into a Share Exchange Agreement (the “Share Exchange”) with Eaton Scientific Systems, Ltd., a Nevada corporation (“ESSL”) and the shareholders of ESSL (the “ESSL Shareholders”), whereby the Company acquired 25,000,000 shares of common stock (100%) of ESSL (the “ESSL Stock”) from the ESSL Shareholders.  In exchange for the ESSL Stock, the Company issued 25,000,000 shares of its common stock to the ESSL Shareholders (the “Share Exchange”).
	The Company’s Chief Executive Officer, Mr. Michael J. Borkowski, and the Company’s controlling shareholder and former President, Ms. Christine Buchanan-McKenzie, entered into a Common Stock Purchase Agreement, whereby Mr. Borkowski would purchase one hundred (100%) percent of the Company’s common shares owned by Mrs. Buchanan-McKenzie, or 240,000,000 shares, at par value $.0001, representing approximately 54.1% of the Company’s total issued and outstanding shares.  The Common Stock Purchase Agreement, and subsequent transaction closing, was completed on October 22, 2012.  On October 23, 2012, the Common Stock Purchase Agreement was finalized, and a change in control of the Company took place.
	In conjunction with the Share Exchange and Common Stock Purchase Agreement, the total shares held by the ESSL Shareholders are 265,000,000, or approximately 59.8% of the issued and outstanding common stock of the Company as of October 30, 2012.  In addition, certain ESSL shareholders owning a total of 135,779,375 shares of the Company’s common stock, representing approximately 30.64% of the issued and outstanding common stock of the Company, entered into three (3) separate twenty-four (24) month Lock-Up Agreements.
	As a result of the Share Exchange and Common Stock Purchase Agreement, (i) there was a change in control of the Company; (ii) ESSL became the Company’s wholly owned subsidiary; and (iii) the ESSL operations continued as its primary business.  In addition, on November 27, 2012, the Company changed its name to Eaton Scientific Systems, Inc.
	In October, 2013, the Company’s Management was introduced to Domenic Marciano (“Marciano”).  Marciano represented that he intended to acquire an exclusive license to a unique automotive product, the EcoFlora Spark Plug, with a proprietary technology, and that EcoFlora has the potential to be uniquely positioned in the automotive parts business in the United States and International automotive parts marketplace.
	The Majority Shareholders acknowledge that the Company has not been able to attract investment capital sufficient to execute its business plan because of its Share price.  Further, Management believes that the potential success of the EcoFlora technology could potentially provide value to the Company and its shareholders. As a result, on November 26, 2013, the Company and its Majority Shareholders (the “Majority Stockholders”) entered into an Agreement for the Purchase of Common Stock (the “Stock Purchase Agreement”) with Marciano whereby Marciano acquired 227,370,000 shares of the Company’s common stock from the Majority Stockholders at par value $.0001, representing approximately 51.3% of the Company’s total issued and outstanding shares, in exchange for cash in the amount of $22,737 (the “Cash Proceeds”).  The Stock Purchase Agreement, and subsequent transaction closing, was completed on November 26, 2013, and a change in control of the Company took place.
	The Majority Shareholders and the Company’s Management also believe it is in the best interest of the Company’s Shareholders to operate Eaton Scientific Systems, Ltd. (“Eaton Sub”) a Nevada corporation and wholly owned subsidiary of the Company, as a privately held Company, until such time where it is sufficiently capitalized to increase the probability for its Clinical Trials of Homatropine (“Tropine 3”) in oral suspension for the treatment of hot flash symptoms in pre-menopausal, menopausal and post menopausal women, to be in a position to yield results that may provide the opportunity for a potential FDA approval for marketing to consumers in the US.
	In connection with the terms and conditions of the Stock Purchase Agreement and sale of 227,370,000 shares held by the Majority Stockholders:
	1. Marciano appointed two new directors to the Company’s board of directors; and
	2. The “Lock-Up-Leak-Out” Agreements executed in October 2012 were cancelled by mutual agreement between the Board and the Company’s Shareholders who were party to the Agreements.
	3. The Majority Shareholders of the Company have voted to “Spin-out” to its Shareholders, one hundred percent (100%) of the issued and outstanding shares of Eaton Scientific Systems Ltd., its operating subsidiary, as of the record date of November 25, 2013, on a one-for-one basis within sixty-days (60) of the Change of Control of the Company, or by January 25, 2014.
	On January 9, 2014, the Spin-out was complete, and Eaton Scientific Systems, Ltd. was no longer a subsidiary of the Company.
	On February 14, 2014, the Company changed its name to Eco Science Solutions, Inc. (OTCQB.ESSI).
	NOTE: The following notes and any further reference made to “the Company”, "we", "us", "our" and "ESSI" shall mean Eco Science Solutions, Inc. (formerly Eaton Scientific Systems, Inc.), unless otherwise indicated.
	Headquartered in Miami, Florida, Eco Science Solutions, Inc., a Nevada corporation, is charged with the origination, development and commercialization of innovative aftermarket automotive parts.
	On December 4, 2013, the Company (the “Company”) executed an Agreement of the License of Intellectual Property (the “License Agreement”) dated November 4, 2013 with Eco Science Solutions International, Inc., a Canadian corporation (“ESS International”), for the exclusive license to a revolutionary Spark Plug technology, the EcoFlora Spark Plug, that has filed for Patent protection in Canada and the United States based on its "Internal Pre-Combustion Chamber High Efficiency Spark Plug" technology. In connection with the License Agreement, the Company issued ESS International 2,500,000 shares of the Company’s Series “A” Convertible Preferred Stock (“Preferred Stock”), in exchange for the exclusive license of the Patent Applications, in perpetuity.  The Preferred Stock is convertible into common stock at a conversion rate of 10 common shares for each preferred share.
	On February 14, 2014, the Company effected a 1000-to-1 reverse stock split.  As a result, the total shares of common stock issued and outstanding was adjusted to 443,001 shares with a par value of $0.10.
	On April 4, 2014, the Company received notice from Eco Science Solutions International, Inc. to convert 100% of the Series “A” preferred shares into restricted common shares on a 10 for 1 basis.  As a result, on April 9, 2014, 25,000,000 shares of the Company’s restricted common stock was issued, of which 19,866,668 shares were issued to the Company’s chairman, Domenic Marciano, and 5,133,332 shares were issued to non-related parties.  Subsequent to the conversion, Eco Science Solutions International, Inc. no longer holds any shares of the Company’s capital stock, and Mr. Marciano holds 20,094,038 shares of the Company’s common stock, which represents 62.13% of the total issued and outstanding shares of the Company’s common stock on a fully diluted basis.
	The Company is currently in the testing and development stages, and intends to validate its technology and then and manufacture and sell the technology.
	Going Concern
	These financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has not generated significant revenues to date and has never paid any dividends and is unlikely to pay dividends or generate significant earnings in the immediate or foreseeable future.  As at July 31, 2014, the Company had a working capital deficit from continuing operations of $349,438, and an accumulated deficit of $8,524,385. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability to raise equity or debt financing, and the attainment of profitable operations from the Company's future business. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern.
	The financial statements reflect all adjustments consisting of normal recurring adjustments, which, in the opinion of management, are necessary for a fair presentation of the results for the periods shown. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2014
Notes	'
Summary of Significant Accounting Policies	'
	NOTE 2: Summary of Significant Accounting Policies
	This summary of significant accounting policies is presented to assist in understanding the Company’s financial statements.  These accounting policies conform to accounting principles, generally accepted in the United States of America, and have been consistently applied in the preparation of the financial statements.
	Basis of Presentation
	These consolidated financial statements and related notes are prepared in accordance with generally accepted accounting principles in the United States and are expressed in US dollars. The Company’s fiscal year end is January 31.
	Development Stage Company
	The Company is a development stage company as defined by ASC 915-10-05, “Development Stage Entity.” The Company is still devoting substantially all of its efforts on establishing the business, and its planned principal operations have not commenced.  All losses accumulated, since inception, have been considered as part of the Company’s development stage activities.
	Use of Estimates
	The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to long-lived assets and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
	Cash and Cash Equivalents
	The Company considers all highly liquid instruments with maturity of three months or less at the time of purchase to be cash equivalents. As of July 31, 2014 and January 31, 2014, the Company had no cash equivalents.
	Intangible Assets
	Intangible assets consist of licensing and other direct costs incurred in connection with the license rights of pending patents, and are capitalized and amortized over the shorter of the economic or legal life of the patent.  During the six months ended July 31, 2014 and the year ended January 31, 2014, respectively, $0 and $5,265,000 were capitalized to patent development costs.
	Impairment of Long-Lived Assets
	The Company’s long-lived assets, including intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the historical-cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset.
	Due to the Company’s recurring losses, the costs related to its patents were evaluated for impairment and it was determined that there were no sufficient estimated future cash flows for the recoverability of the asset.  As a result, an impairment loss of $5,265,000 was recorded for the year ended January 31, 2014.
	Fair Value Measurements
	Pursuant to ASC 820, Fair Value Measurements and Disclosures and ASC 825, Financial Instruments, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 and 825 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 and 825 prioritizes the inputs into three levels that may be used to measure fair value:
	Ÿ	Level 1	Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
	Ÿ	Level 2	Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
	Ÿ	Level 3	Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
	The Company’s financial instruments consist principally of cash, accounts payable, and accrued liabilities. Pursuant to ASC 820 and 825, the fair value of cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.
	Revenue Recognition
	The Company recognizes revenue in accordance with ASC 605, Revenue Recognition. Revenue is recognized only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service has been provided, and collectability is reasonably assured.  As of July 31, 2014, no revenue has been recognized, as the Company has not commenced operations.
	Stock-Based Compensation
	The Company records stock-based compensation in accordance with ASC 718, Share-Based Payments, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued.
	Basic and Diluted Net Income (Loss) Per Share
	The Company computes net income (loss) per share in accordance with ASC 260, Earning per Share.  ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti dilutive.
	Discontinued Operations
	In accordance with ASC 205-20 and ASU 2014-08, Presentation of Financial Statements - Discontinued Operations, the Company reported the results of its former subsidiary, Eaton Scientific Solutions, Ltd. (“Eaton Sub”), as a discontinued operation in the Company’s annual financial statements for the year ended January 31, 2014. The application of ASC 205-20 and the adoption of ASU 2014-08 are discussed therein.
	Comprehensive Loss
	ASC 220, Comprehensive Income, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. As at July 31, 2014, the Company has no items that represent comprehensive loss and, therefore, has not included a schedule of comprehensive loss in the financial statements.
	Recently Adopted Accounting Standards:
	The Company evaluates the pronouncements of various authoritative accounting organizations, primarily the Financial Accounting Standards Board (“FASB”), the US Securities and Exchange Commission (“SEC”), and the Emerging Issues Task Force (“EITF”), to determine the impact of new pronouncements on US GAAP and the impact on the Company. The Company has recently adopted the following new accounting standards:
	Adopted:
	Effective January 2012, the Company adopted ASU No. 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs (ASU 2011-04). ASU 2011-04 represents the converged guidance of the Financial Accounting Standards Board (FASB) and the International Accounting Standards Board (IASB) on fair value measurement. A variety of measures are included in the update intended to either clarify existing fair value measurement requirements, change particular principles requirements for measuring fair value or for disclosing information about fair value measurements. For many of the requirements, the FASB does not intend to change the application of existing requirements under Accounting Standards Codification (ASC) Topic 820, Fair Value Measurements. ASU 2011-04 was effective for interim and annual periods beginning after December 15, 2011. The adoption of this update did not have a material impact on the consolidated financial statements.
	Effective January 2012, the Company adopted ASU No. 2011-05, Presentation of Comprehensive Income (ASU 2011-05). ASU 2011-05 is intended to increase the prominence of items reported in other comprehensive income and to facilitate convergence of accounting guidance in this area with that of the IASB. The amendments require that all non-owner changes in shareholders’ equity be presented in a single continuous statement of comprehensive income or in two separate but consecutive statements. In December 2011, the FASB issued ASU No. 2011-12, Comprehensive Income (Topic 220): Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05 (ASU 2011-12). ASU 2011-12 defers the provisions of ASU 2011-05 that require the presentation of reclassification adjustments on the face of both the statement of income and statement of other comprehensive income. Amendments under ASU 2011-05 that were not deferred under ASU 2011-12 will be applied retrospectively for fiscal years, and interim periods within those years, beginning after December 15, 2011. The adoption of this update did not have a material impact on the consolidated financial statements.
	In April 2013, the FASB issued ASU No. 2013-07, Presentation of Financial Statements (Top 205): Liquidation Basis of Accounting. The objective of ASU No. 2013-07 is to clarify when an entity should apply the liquidation basis of accounting and to provide principles for the measurement of assets and liabilities under the liquidation basis of accounting, as well as any required disclosures. The amendments in this standard is effective prospectively for entities that determine liquidation is imminent during annual reporting periods beginning after December 15, 2013, and interim reporting periods therein. The Company is evaluating the effect, if any, the adoption of ASU No. 2013-07 may have on its consolidated financial statements.
	In April 2014, the FASB issued ASU No. 2014-08 Presentation of Financial Statements (Top 205): Reporting Discontinued Operations and Disclosure of Disposals of Components of an Entity.  The objective of ASU No. 2014-08 is to clarify the criteria for determining which disposals can be presented as discontinued operations and also modifies related disclosure requirements. The standard is required to be adopted by public business entities in annual periods beginning on or after December 15, 2014, and interim periods within those annual periods.  Early adoption is permitted for new disposals beginning in the first quarter of 2014, provided financial statements have not been issued before the release of this standard.
	Not Yet Adopted:
	In February 2013, the FASB issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive (ASU 2013-02). This guidance is the culmination of the FASB’s deliberation on reporting reclassification adjustments from accumulated other comprehensive income (AOCI). The amendments in ASU 2013-02 do not change the current requirements for reporting net income or other comprehensive income. However, the amendments require disclosure of amounts reclassified out of AOCI in its entirety, by component, on the face of the statement of operations or in the notes thereto. Amounts that are not required to be reclassified in their entirety to net income must be cross-referenced to other disclosures that provide additional detail. This standard is effective prospectively for annual and interim reporting periods beginning after December 15, 2012. The Company is evaluating the effect, if any, the adoption of ASU 2013-02 may have on its consolidated financial statements.
	In July 2013, the FASB issued ASU No 2013-11, Presentation of an Unrecognized Tax Benefit When Net Operating Loss Carryforward Exists.  The objective of ASU 2013-11 is to reduce diversity in practice by providing guidance on the presentation of unrecognized tax benefits, and will better reflect the manner in which an entity would settle at the reporting date any additional income taxes that would result from the disallowance of a tax position when net operating loss carryforwards, similar tax losses, or tax credit carryforwards exist. The amendments in this Update are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013, and interim reporting periods therein. Early adoption is permitted. The Company is evaluating the effect, if any, adoption of ASU No. 2013-11 will have on its consolidated financial statements.
	Recently Issued Accounting Standards Updates:
	There were various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries. None of the updates are expected to a have a material impact on the Company's consolidated financial position, results of operations or cash flows.

Notes_and_Loans_Payable

Notes and Loans Payable	6 Months Ended
	Jul. 31, 2014
Notes	'
Notes and Loans Payable	'
	NOTE 3: NOTES AND LOANS PAYABLE-CONVERTIBLE
	On January 7, 2013, the Company issued a Convertible Promissory Note in the amount of $250,000 to a non-related party (the “Convertible Note”).  The Convertible Note and accrued interest was subsequently purchased and assigned to another non-related party as part of a Convertible Note Assignment and Purchase Agreement (the “Assignment”) dated August 18, 2013.  The Convertible Note is payable within two (2) years, or by January 31, 2015, accrues interest at a rate of 6% per annum, and is convertible into the Company’s common stock at a rate of $0.003 per share. In accordance with certain Assignment of Debt agreements dated April 16, 2014, April 29, 2914, and June 27, 2014, total principal in the amount of $9,450 was assigned to three non-related parties (the “Assignees”), transferring all the rights of the original Convertible Note. Interest in the amount of $23,310 and $15,986 has been accrued as of July 31, 2014 and January 31, 2014, respectively, and is included as an accrued expense on the accompanying balance sheets.
	On April 29, 2014, the Company received notice from an Assignee to convert 100% of the Assignee’s $3,000 note into the Company’s common stock at the conversion rate of $0.003 per share.  As a result, 1,000,000 unrestricted shares of the Company’s common stock were issued to the Assignee.
	On April 29, 2014, the Company received notice from an Assignee to convert 100% of the Assignee’s $3,450 note into the Company’s common stock at the conversion rate of $0.003 per share.  As a result, 1,150,000 unrestricted shares of the Company’s common stock were issued to the Assignee.
	On June 27, 2014, the Company received notice from an Assignee to convert 100% of the Assignee’s $3,000 note into the Company’s common stock at the conversion rate of $0.003 per share.  As a result, 1,000,000 unrestricted shares of the Company’s common stock were issued to the Assignee.
	In connection with the Assignments of Debt and subsequent conversions of debt, the principal balance of the Convertible Note was reduced to $240,550.
	As of July 31, 2014 and January 31, 2014, respectively, the Company has accrued $23,310 and $15,986 in interest on notes and loans payable.

Related_Party_Transactions

Related Party Transactions	6 Months Ended
	Jul. 31, 2014
Notes	'
Related Party Transactions	'
	NOTE 4: Related Party Transactions
	As of July 31, 2014, related parties are due a total of $149,819, which is comprised of $91,569 in cash loans to the Company, and $58,250 in accrued compensation.
	Related party transactions consist of the following:
		31-Jul-14		31-Jan-14
	Related party payable-compensation	$	58,250	$	58,250
	Notes payable for loans to the Company		22,000		22,000
	Convertible notes payable for loans to the Company		69,569		16,991
	Total related party loans		91,569		38,991
	Total related party transactions	$	149,819	$	97,241
	On September 1, 2012, the Company entered into an employment agreement with Mr. Michael J. Borkowski (the “2012 Employment Agreement”) to serve as the Company’s President, CEO, and Director. The Employment Agreement was for a term of three (3) years, and included compensation in the amount of $72,000 per year, bonus compensation in the amount of $100,000 contingent upon the Company meeting certain goals, 5,000,000 stock options, and certain other benefits in the event they are offered by the Company in the future. As a result of the change in control of the Company in November 2013, the 5,000,000 stock options granted under the 2012 Employment Agreement became fully vested (see Note 9). As of July 31, 2014 and January 31, 2014, $59,000 has been recorded as a related party payable for unpaid compensation under the 2012 Employment Agreement.
	On November 15, 2013, the Company entered into a new employment agreement with Mr. Michael J. Borkowski (the “2013 Employment Agreement”) to serve under new management as the Company’s President, CEO, and Director. The Employment Agreement, which replaces the 2012 Employment Agreement, is for a term of one (1) year, and includes compensation in the amount of $18,000 per year, compensation for certain travel expenses, and grants to purchase 400,000 shares of the Company’s common stock at par, which vest periodically beginning February 15, 2014, at 100,000 shares per vesting period through November 15, 2014 (the “Stock Award”). In connection with the Stock Award, $640,000 has been recorded as deferred compensation, of which $480,000 has been expensed in the current year.  There remains $160,000 in deferred compensation to be amortized over the next 4 months. As of July 31, 2014 and January 31, 2014, $750 has been recorded as prepaid related party compensation under the 2013 Employment Agreement.
	On November 4, 2013, the Company issued a Promissory Note (the “Note”) in the amount of $22,000 to Eco Science Solutions International, Inc., a company controlled by Domenic Marciano, the Company’s chairman, for cash loans made to the Company.  The Note bears interest at a rate of 5% per annum and is due within ninety (90) days of written demand. As of July 31, 2014, the Note remains unpaid, and no demand has been made.  Interest in the amount of $811 and $265 has been accrued as of July 31, 2014 and January 31, 2014, respectively, and is included as an accrued expense on the accompanying balance sheets.
	On January 31, 2014, the Company issued a Convertible Promissory Note (the “Convertible Note”) in the amount of $16,991 to Eco Science Solutions International, Inc., a company controlled by Domenic Marciano, the Company’s chairman, for cash loans made to the Company.  Modifications to the Convertible Note have been made through July 31, 2014to increase the principal by $52,578, representing additional cash loans made to the Company for overhead advances. The Convertible Note bears interest at a rate of 5% per annum, is due within two (2) years, or January 31, 2016, and is convertible into the Company’s common stock at a rate equal to the fair market value on the date of conversion. As of July 31, 2014, the Note remains unpaid, and no demand has been made. Interest in the amount of $869 and $0 has been accrued as of July 31, 2014 and January 31, 2014, respectively, and is included as an accrued expense on the accompanying balance sheets.
	On April 9, 2014, in connection with the conversion of certain preferred stock, Domenic Marciano, the Company’s chairman, was issued 19,866,668 of the Company’s common stock (see Note 6).
	As of July 31, 2014 and January 31, 2014, respectively, the Company has accrued $1,680 and $265 in interest on related party loans.

Commitments_and_Contingencies

Commitments and Contingencies	6 Months Ended
	Jul. 31, 2014
Notes	'
Commitments and Contingencies	'
	NOTE 5: COMMITMENTS AND CONTINGENCIES
	On December 4, 2013, the Company (the “Company,” the “Licensee”) executed an Agreement of the License of Intellectual Property (“License Agreement”) dated November 4, 2013 with Eco Science Solutions International, Inc., a Canadian corporation (“Licensor”), for the license of certain US and Canadian Patent Pending Applications in perpetuity.  In connection with the terms and conditions of the License Agreement, the Company will pay Licensor a royalty equal to three percent (3%) of Gross Revenues (the “Gross Revenues”) earned in connection with the Patent License, payable on a quarterly basis.  As of July 31, 2014, no Gross Revenues have been earned.

Preferred_Stock

Preferred Stock	6 Months Ended
	Jul. 31, 2014
Notes	'
Preferred Stock	'
	NOTE 6: PREFERRED STOCK
	The total number of authorized shares of preferred stock that may be issued by the Company is 50,000,000 shares with a par value of $0.001.
	On December 4, 2013, in connection with the Agreement of the License of Intellectual Property dated November, 4, 3013, the Company issued 2,500,000 shares of Series “A” Convertible Preferred Stock to Eco Science Solutions International, Inc., a company controlled by Domenic Marciano, the Company’s chairman, valued at $5,265,000. As a result, $5,262,500 was recorded as preferred additional paid in capital.  The Preferred Stock is convertible into the Company’s common stock at a rate of 10 shares of common stock for each share of Preferred Stock.
	On April 4, 2014, the Company received notice from Eco Science Solutions International, Inc. to convert 100% of the Series “A” preferred shares into restricted common shares on a 10 for 1 basis.  As a result, on April 9, 2014, 25,000,000 shares of the Company’s restricted common stock were issued, and preferred additional paid in capital was reduced by -$5,262,500.
	As of July 31, 2014, no shares of the Company’s preferred stock were issued and outstanding.

Common_Stock

Common Stock	6 Months Ended
	Jul. 31, 2014
Notes	'
Common Stock	'
	NOTE 7: COMMON STOCK
	The following reflects the common stock transactions as adjusted for the change in par value, and the effects of the 1000-to-1 reverse stock-split that occurred on February 14, 2014.
	The total number of authorized shares of common stock that may be issued by the Company is 650,000,000 shares with a par value of $0.10.
	On April 29, 2014, the Company received notice from the holder of a $3,450 Convertible Note Payable to convert 100% of principal into the Company’s common stock at the conversion rate of $0.003 per share.  As a result, 1,150,000 unrestricted shares of the Company’s common stock, with a par value of $115,000, were issued to the note holder, and additional paid in capital was reduced by -$111,550.
	On June 27, 2014, the Company received notice from the holder of a $3,000 Convertible Note Payable to convert 100% of principal into the Company’s common stock at the conversion rate of $0.003 per share.  As a result, 1,000,000 unrestricted shares of the Company’s common stock, with a par value of $100,000, were issued to the note holder, and additional paid in capital was reduced by -$97,000.
	On July 15, 2014, in accordance with his Employment Agreement, the Company issued 100,000 shares of restricted common stock, valued at $160,000, to its President for cash in the amount of $100. As a result, additional paid in capital was reduced by -$9,900.
	As of July 31, 2014 and January 31, 2014, respectively, 28,893,001 and 443,001 shares of the Company’s common stock were issued and outstanding.

Warrants_and_Options

Warrants and Options	6 Months Ended
	Jul. 31, 2014
Notes	'
Warrants and Options	'
	NOTE 8: WARRANTS AND OPTIONS
	On September 1, 2012, the Company, under its 2012 Plan, granted qualified stock options to purchase 6,500,000 shares of its common stock.  Of the total options granted, 5,000,000 were granted to the President of the Company (the “Executive Options”) at $0.10 per share, and 1,500,000 were granted to a consultant at $0.25 per share (collectively, the “Options”).  The Options are exercisable for a period of five (5) years, vest quarterly over a period of three (3) years, and were valued using the Black-Scholes valuation method at $0.41 per share, or $2,665,000, to be amortized over a 36-month period.
	Options Outstanding
					Remaining	Exercise Price		Weighted
			Number of		Contractual Life	times Number		Average
	Exercise Price		Shares		(in years)	of Shares		Exercise Price
	$0.10		5,000,000		3.25	$	500,000	$0.10
	$0.25		1,500,000		3.25		375,000	$0.25
			6,500,000			$	875,000	$0.20
	Options Activity			Weighted
		Number		Average
		of Shares		Exercise Price
	Outstanding at January 31, 2014	6,500,000		$0.20
	Issued	––		––
	Exercised	––		––
	Expired / Cancelled	––		––
	Outstanding at July 31, 2014	6,500,000		$0.20
	As of July 31, 2014 and January 31, 2014, the Company has granted a total of 6,500,000 options to purchase common stock shares. In connection with the options granted, a total of $2,665,000 has been recorded as deferred compensation, of which $102,500 and $2,084,617 has been expensed during the six months ended July 31, 2014 and the year ended January 31, 2014, respectively. There remains $256,250 and $358,750 of deferred compensation as of July 31, 2014 and January 31, 2014, respectively.

Restricted_Stock_Awards

Restricted Stock Awards	6 Months Ended
	Jul. 31, 2014
Notes	'
Restricted Stock Awards	'
	NOTE 9: RESTRICTED STOCK AWARDS
	On February 15, 2014, in connection with a certain Employment Agreement dated November 15, 2013, its President was awarded the right to purchase 400,000 shares of the Company’s restricted common stock (the “Restricted Stock Units”, “RSUs”) at a per share price of $0.001 (the “Stock Award”).  The Stock Award, valued at $640,000, vests periodically over the period beginning February 15, 2014 through November 15, 2014, at 100,000 RSUs per vesting period.  During the six month period ended July 31, 2014, the Company recorded deferred compensation in the amount of $640,000, of which $480,000 has been expensed in the current year for the 300,000 RSUs vested through July 15, 2014.  There remains $160,000 in deferred compensation to be amortized over the next 4 months.
	Restricted Stock Units Activity			Weighted
		Number		Average
		of RSUs		Exercise Price
	Outstanding at January 31, 2014	––		––
	Awarded	400,000		$0.00
	Exercised / Vested	(300,000	)	$0.00
	Expired / Cancelled	––		––
	Outstanding at July 31, 2014	100,000		$0.00
	As of July 31, 2014, the Company has awarded a total of 400,000 Restricted Stock Units. In connection with the Stock Award, a total of $640,000 has been recorded as deferred compensation, of which $480,000 has been expensed as of July 31, 2014. There remains $160,000 of deferred compensation as of July 31, 2014.

Income_Taxes

Income Taxes	6 Months Ended
	Jul. 31, 2014
Notes	'
Income Taxes	'
	NOTE 10: INCOME TAXES
	The components of the net change in deferred tax asset at July 31, 2014 and January 31, 2014, the statutory tax rate, the effective tax rate and the amount of the valuation allowance are indicated below:
		31-Jul-14			31-Jan-14
	Income (loss) before taxes:
	Continuing operations	$	(631,844	)	$	(7,452,402	)
	Discontinued operations		––			(384,505	)
	Total income (loss) before taxes		(631,844	)		(7,836,907	)
	Statutory rate		34%			34%
	Computed expected tax payable (recovery)	$	(214,800	)	$	(2,664,400	)
	Non-deductible expenses		––			1,000
	Change in valuation allowance		214,800			2,663,400
	Reported income taxes	$	––		$	––
	The significant components of the cumulative deferred income tax assets and liabilities at July 31, 2014 and January 31, 2014, are as follows:
		31-Jul-14			31-Jan-14
	Deferred tax assets:
	Continuing operations:
	Net operating loss carry forward	$	2,834,800		$	2,620,000
	Less valuation allowance		(2,834,800	)		(2,620,000	)
	Net deferred tax asset - continuing operations	$	––		$	––
	Discontinued operations:
	Net operating loss carry forward	$	263,700		$	263,700
	Less valuation allowance		(263,700	)		(263,700	)
	Net deferred tax asset - discontinued operations	$	––		$	––

Subsequent_Events

Subsequent Events	6 Months Ended
	Jul. 31, 2014
Notes	'
Subsequent Events	'
	NOTE 11: SUBSEQUENT EVENTS
	The Company has evaluated the events and transactions for recognition or disclosure subsequent to July 31, 2014 and through September 15, 2014, and has determined that there have been no events that would require disclosure.

Nature_of_Business_and_Continu1

Nature of Business and Continuance of Operations (Policies)	6 Months Ended
	Jul. 31, 2014
Policies	'
Going Concern	'
	Going Concern
	These financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has not generated significant revenues to date and has never paid any dividends and is unlikely to pay dividends or generate significant earnings in the immediate or foreseeable future.  As at July 31, 2014, the Company had a working capital deficit from continuing operations of $349,438, and an accumulated deficit of $8,524,385. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability to raise equity or debt financing, and the attainment of profitable operations from the Company's future business. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern.
	The financial statements reflect all adjustments consisting of normal recurring adjustments, which, in the opinion of management, are necessary for a fair presentation of the results for the periods shown. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2014
Policies	'
Basis of Presentation	'
	Basis of Presentation
	These consolidated financial statements and related notes are prepared in accordance with generally accepted accounting principles in the United States and are expressed in US dollars. The Company’s fiscal year end is January 31.
Development Stage Company	'
	Development Stage Company
	The Company is a development stage company as defined by ASC 915-10-05, “Development Stage Entity.” The Company is still devoting substantially all of its efforts on establishing the business, and its planned principal operations have not commenced.  All losses accumulated, since inception, have been considered as part of the Company’s development stage activities.
Use of Estimates, Policy	'
	Use of Estimates
	The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to long-lived assets and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
Cash and Cash Equivalents, Policy	'
	Cash and Cash Equivalents
	The Company considers all highly liquid instruments with maturity of three months or less at the time of purchase to be cash equivalents. As of July 31, 2014 and January 31, 2014, the Company had no cash equivalents.
Intangible Assets	'
	Intangible Assets
	Intangible assets consist of licensing and other direct costs incurred in connection with the license rights of pending patents, and are capitalized and amortized over the shorter of the economic or legal life of the patent.  During the six months ended July 31, 2014 and the year ended January 31, 2014, respectively, $0 and $5,265,000 were capitalized to patent development costs.
Impairment of Long-lived Assets	'
	Impairment of Long-Lived Assets
	The Company’s long-lived assets, including intangibles, are reviewed for impairment whenever events or changes in circumstances indicate that the historical-cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset.
	Due to the Company’s recurring losses, the costs related to its patents were evaluated for impairment and it was determined that there were no sufficient estimated future cash flows for the recoverability of the asset.  As a result, an impairment loss of $5,265,000 was recorded for the year ended January 31, 2014.
Financial Instruments	'
	Fair Value Measurements
	Pursuant to ASC 820, Fair Value Measurements and Disclosures and ASC 825, Financial Instruments, an entity is required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 and 825 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 and 825 prioritizes the inputs into three levels that may be used to measure fair value:
	Ÿ	Level 1	Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.
	Ÿ	Level 2	Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.
	Ÿ	Level 3	Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
	The Company’s financial instruments consist principally of cash, accounts payable, and accrued liabilities. Pursuant to ASC 820 and 825, the fair value of cash is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. The recorded values of all other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations.
Revenue Recognition	'
	Revenue Recognition
	The Company recognizes revenue in accordance with ASC 605, Revenue Recognition. Revenue is recognized only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service has been provided, and collectability is reasonably assured.  As of July 31, 2014, no revenue has been recognized, as the Company has not commenced operations.
Stock-based Compensation	'
	Stock-Based Compensation
	The Company records stock-based compensation in accordance with ASC 718, Share-Based Payments, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued.
Basic and Diluted Net Income (loss) Per Share	'
	Basic and Diluted Net Income (Loss) Per Share
	The Company computes net income (loss) per share in accordance with ASC 260, Earning per Share.  ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti dilutive.
Discontinued Operations	'
	Discontinued Operations
	In accordance with ASC 205-20 and ASU 2014-08, Presentation of Financial Statements - Discontinued Operations, the Company reported the results of its former subsidiary, Eaton Scientific Solutions, Ltd. (“Eaton Sub”), as a discontinued operation in the Company’s annual financial statements for the year ended January 31, 2014. The application of ASC 205-20 and the adoption of ASU 2014-08 are discussed therein.
Comprehensive Loss	'
	Comprehensive Loss
	ASC 220, Comprehensive Income, establishes standards for the reporting and display of comprehensive loss and its components in the financial statements. As at July 31, 2014, the Company has no items that represent comprehensive loss and, therefore, has not included a schedule of comprehensive loss in the financial statements.
Recent Accounting Pronouncements	'
	Recently Adopted Accounting Standards:
	The Company evaluates the pronouncements of various authoritative accounting organizations, primarily the Financial Accounting Standards Board (“FASB”), the US Securities and Exchange Commission (“SEC”), and the Emerging Issues Task Force (“EITF”), to determine the impact of new pronouncements on US GAAP and the impact on the Company. The Company has recently adopted the following new accounting standards:
	Adopted:
	Effective January 2012, the Company adopted ASU No. 2011-04, Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs (ASU 2011-04). ASU 2011-04 represents the converged guidance of the Financial Accounting Standards Board (FASB) and the International Accounting Standards Board (IASB) on fair value measurement. A variety of measures are included in the update intended to either clarify existing fair value measurement requirements, change particular principles requirements for measuring fair value or for disclosing information about fair value measurements. For many of the requirements, the FASB does not intend to change the application of existing requirements under Accounting Standards Codification (ASC) Topic 820, Fair Value Measurements. ASU 2011-04 was effective for interim and annual periods beginning after December 15, 2011. The adoption of this update did not have a material impact on the consolidated financial statements.
	Effective January 2012, the Company adopted ASU No. 2011-05, Presentation of Comprehensive Income (ASU 2011-05). ASU 2011-05 is intended to increase the prominence of items reported in other comprehensive income and to facilitate convergence of accounting guidance in this area with that of the IASB. The amendments require that all non-owner changes in shareholders’ equity be presented in a single continuous statement of comprehensive income or in two separate but consecutive statements. In December 2011, the FASB issued ASU No. 2011-12, Comprehensive Income (Topic 220): Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items Out of Accumulated Other Comprehensive Income in Accounting Standards Update No. 2011-05 (ASU 2011-12). ASU 2011-12 defers the provisions of ASU 2011-05 that require the presentation of reclassification adjustments on the face of both the statement of income and statement of other comprehensive income. Amendments under ASU 2011-05 that were not deferred under ASU 2011-12 will be applied retrospectively for fiscal years, and interim periods within those years, beginning after December 15, 2011. The adoption of this update did not have a material impact on the consolidated financial statements.
	In April 2013, the FASB issued ASU No. 2013-07, Presentation of Financial Statements (Top 205): Liquidation Basis of Accounting. The objective of ASU No. 2013-07 is to clarify when an entity should apply the liquidation basis of accounting and to provide principles for the measurement of assets and liabilities under the liquidation basis of accounting, as well as any required disclosures. The amendments in this standard is effective prospectively for entities that determine liquidation is imminent during annual reporting periods beginning after December 15, 2013, and interim reporting periods therein. The Company is evaluating the effect, if any, the adoption of ASU No. 2013-07 may have on its consolidated financial statements.
	In April 2014, the FASB issued ASU No. 2014-08 Presentation of Financial Statements (Top 205): Reporting Discontinued Operations and Disclosure of Disposals of Components of an Entity.  The objective of ASU No. 2014-08 is to clarify the criteria for determining which disposals can be presented as discontinued operations and also modifies related disclosure requirements. The standard is required to be adopted by public business entities in annual periods beginning on or after December 15, 2014, and interim periods within those annual periods.  Early adoption is permitted for new disposals beginning in the first quarter of 2014, provided financial statements have not been issued before the release of this standard.
	Not Yet Adopted:
	In February 2013, the FASB issued ASU No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive (ASU 2013-02). This guidance is the culmination of the FASB’s deliberation on reporting reclassification adjustments from accumulated other comprehensive income (AOCI). The amendments in ASU 2013-02 do not change the current requirements for reporting net income or other comprehensive income. However, the amendments require disclosure of amounts reclassified out of AOCI in its entirety, by component, on the face of the statement of operations or in the notes thereto. Amounts that are not required to be reclassified in their entirety to net income must be cross-referenced to other disclosures that provide additional detail. This standard is effective prospectively for annual and interim reporting periods beginning after December 15, 2012. The Company is evaluating the effect, if any, the adoption of ASU 2013-02 may have on its consolidated financial statements.
	In July 2013, the FASB issued ASU No 2013-11, Presentation of an Unrecognized Tax Benefit When Net Operating Loss Carryforward Exists.  The objective of ASU 2013-11 is to reduce diversity in practice by providing guidance on the presentation of unrecognized tax benefits, and will better reflect the manner in which an entity would settle at the reporting date any additional income taxes that would result from the disallowance of a tax position when net operating loss carryforwards, similar tax losses, or tax credit carryforwards exist. The amendments in this Update are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013, and interim reporting periods therein. Early adoption is permitted. The Company is evaluating the effect, if any, adoption of ASU No. 2013-11 will have on its consolidated financial statements.
	Recently Issued Accounting Standards Updates:
	There were various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries. None of the updates are expected to a have a material impact on the Company's consolidated financial position, results of operations or cash flows.

Related_Party_Transactions_Sch

Related Party Transactions: Schedule of Related Party Transactions (Tables)	6 Months Ended
	Jul. 31, 2014
Tables/Schedules	'
Schedule of Related Party Transactions	'
	Related party transactions consist of the following:
		31-Jul-14		31-Jan-14
	Related party payable-compensation	$	58,250	$	58,250
	Notes payable for loans to the Company		22,000		22,000
	Convertible notes payable for loans to the Company		69,569		16,991
	Total related party loans		91,569		38,991
	Total related party transactions	$	149,819	$	97,241

Warrants_and_Options_Schedule_

Warrants and Options: Schedule of Options Outstanding (Tables)	6 Months Ended
	Jul. 31, 2014
Tables/Schedules	'
Schedule of Options Outstanding	'
	Options Outstanding
			Remaining	Exercise Price		Weighted
		Number of	Contractual Life	times Number		Average
	Exercise Price	Shares	(in years)	of Shares		Exercise Price
	$0.10	5,000,000	3.25	$	500,000	$0.10
	$0.25	1,500,000	3.25		375,000	$0.25
		6,500,000		$	875,000	$0.20

Warrants_and_Options_Schedule_1

Warrants and Options: Schedule of Options Activity (Tables)	6 Months Ended
	Jul. 31, 2014
Tables/Schedules	'
Schedule of Options Activity	'
	Options Activity		Weighted
		Number	Average
		of Shares	Exercise Price
	Outstanding at January 31, 2014	6,500,000	$0.20
	Issued	––	––
	Exercised	––	––
	Expired / Cancelled	––	––
	Outstanding at July 31, 2014	6,500,000	$0.20

Restricted_Stock_Awards_Schedu

Restricted Stock Awards: Schedule of RSU Activity (Tables)	6 Months Ended
	Jul. 31, 2014
Tables/Schedules	'
Schedule of RSU Activity	'
	Restricted Stock Units Activity			Weighted
		Number		Average
		of RSUs		Exercise Price
	Outstanding at January 31, 2014	––		––
	Awarded	400,000		$0.00
	Exercised / Vested	(300,000	)	$0.00
	Expired / Cancelled	––		––
	Outstanding at July 31, 2014	100,000		$0.00

Income_Taxes_Schedule_of_Effec

Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Tables)	6 Months Ended
	Jul. 31, 2014
Tables/Schedules	'
Schedule of Effective Income Tax Rate Reconciliation	'
		31-Jul-14			31-Jan-14
	Income (loss) before taxes:
	Continuing operations	$	(631,844	)	$	(7,452,402	)
	Discontinued operations		––			(384,505	)
	Total income (loss) before taxes		(631,844	)		(7,836,907	)
	Statutory rate		34%			34%
	Computed expected tax payable (recovery)	$	(214,800	)	$	(2,664,400	)
	Non-deductible expenses		––			1,000
	Change in valuation allowance		214,800			2,663,400
	Reported income taxes	$	––		$	––

Income_Taxes_Schedule_of_Compo

Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Tables)	6 Months Ended
	Jul. 31, 2014
Tables/Schedules	'
Schedule of Components of Income Tax Expense (Benefit)	'
		31-Jul-14			31-Jan-14
	Deferred tax assets:
	Continuing operations:
	Net operating loss carry forward	$	2,834,800		$	2,620,000
	Less valuation allowance		(2,834,800	)		(2,620,000	)
	Net deferred tax asset - continuing operations	$	––		$	––
	Discontinued operations:
	Net operating loss carry forward	$	263,700		$	263,700
	Less valuation allowance		(263,700	)		(263,700	)
	Net deferred tax asset - discontinued operations	$	––		$	––

Nature_of_Business_and_Continu2

Nature of Business and Continuance of Operations: Share Exchange (Details) (Eaton Scientific Systems, Ltd.)	12 Months Ended
	Jan. 31, 2013
Eaton Scientific Systems, Ltd.	'
Business Combination, Date of Agreement	23-Aug-12
Business Combination, Shares Acquired	25,000,000
Business Combination, Shares Acquired, Percent	100.00%
Business Combination, Shares Issued in Exchange	25,000,000
Business Combination, Total Shares Held by Acquiree	265,000,000
Business Combination, Total Shares Held by Acquiree, Percentage	59.80%
Business Combination, Total Shares Held by Lock-Up Agreements	135,779,375
Business Combination, Total Shares Held by Lock-Up Agreements, Percent	30.64%
Business Combination, Total Shares Held by Lock-Up Agreements, Term (in months)	24

Nature_of_Business_and_Continu3

Nature of Business and Continuance of Operations: Change In Control (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Details	'
Stock Purchase Agreement, Date	26-Nov-13
Stock Purchase Agreement, Common Stock, Number of Shares	227,370,000
Stock Purchase Agreement, Common Stock, Price Per Share	$0.00
Stock Purchase Agreement, Common Stock, Percentage	51.30%
Stock Purchase Agreement, Common Stock, Proceeds	$22,737
Stock Purchase Agreement, Other Terms	'“Spin-out” to its Shareholders, one hundred percent (100%) of the issued and outstanding shares of Eaton Scientific Systems Ltd
Stock Purchase Agreement, Spin Off Date	9-Jan-14

Nature_of_Business_and_Continu4

Nature of Business and Continuance of Operations: License of Intellectual Property (Details) (Eco Science Solutions International, Inc.)	6 Months Ended
	Jul. 31, 2014
Eco Science Solutions International, Inc.	'
License Agreement, Date	4-Nov-13
License Agreement, Patent	'EcoFlora Spark Plug
License Agreement, Preferred Shares Issued	2,500,000
License Agreement, Term	'in perpetuity
License Agreement, Conversion Feature, Common Shares	10

Nature_of_Business_and_Continu5

Nature of Business and Continuance of Operations: Reverse Stock Split (Details) (USD $)	6 Months Ended
	Jul. 31, 2014
Details	'
Stock Split, Date	14-Feb-14
Stock Split, Ratio	'1000-to-1
Stock Split, Adjusted Common Shares	443,001
Stock Split, Adjusted Par Value	$0.10

Nature_of_Business_and_Continu6

Nature of Business and Continuance of Operations: Conversion of Preferred Shares (Details) (Eco Science Solutions International, Inc.)	12 Months Ended
	Jan. 31, 2014
Eco Science Solutions International, Inc.	'
Conversion of Preferred Stock, Date of Notice	4-Apr-14
Conversion of Preferred Stock, Terms of Conversion	'10 for 1 basis
Conversion of Preferred Stock, Common Shares Issued, Date	9-Apr-14
Conversion of Preferred Stock, Common Shares Issued	25,000,000
Conversion of Preferred Stock, Common Shares Issued, Related Party	19,866,668
Conversion of Preferred Stock, Related Party	'Domenic Marciano
Conversion of Preferred Stock, Common Shares Issued, Non-Related Party	5,133,332
Conversion of Preferred Stock, Total Shares Held, Related Party	20,094,038
Conversion of Preferred Stock, Total Shares Held, Related Party, Percentage (fully diluted)	62.13%

Nature_of_Business_and_Continu7

Nature of Business and Continuance of Operations: Going Concern (Details) (USD $)	Jul. 31, 2014
Details	'
Working Capital Deficit	$349,438
Deficit Accumulated During Development Stage	$8,524,385

Summary_of_Significant_Account2

Summary of Significant Accounting Policies: Intangible Assets (Details) (USD $)	6 Months Ended	12 Months Ended
	Jul. 31, 2014	Jan. 31, 2014
Details	'	'
Intangible Assets, Additions During Period	$0	$5,265,000

Summary_of_Significant_Account3

Summary of Significant Accounting Policies: Impairment of Long-lived Assets (Details) (USD $)	12 Months Ended
	Jan. 31, 2014
Details	'
Impairment Loss on Patent	$5,265,000

Notes_and_Loans_Payable_Detail

Notes and Loans Payable (Details) (USD $)	6 Months Ended	12 Months Ended
	Jul. 31, 2014	Jan. 31, 2014
Convertible Promissory Note, Accrued Interest	$23,310	$15,986
Convertible Promissory Note, Principal After Assignment	240,550	'
Convertible Debt	'	'
Convertible Promissory Note, Date Issued	7-Jan-13	'
Convertible Promissory Note, Principal, Before Assignments	250,000	'
Convertible Promissory Note, Term (in years)	2	'
Convertible Promissory Note, Maturity Date	31-Jan-15	'
Convertible Promissory Note, Interest Rate	6.00%	'
Convertible Promissory Note, Conversion Rate	$0.00	'
Convertible Promissory Note, Assignment, Date	16-Apr-14	'
Convertible Promissory Note, Assignment, Date	29-Apr-14	'
Convertible Promissory Note, Assignment, Date	27-Jun-14	'
Convertible Promissory Note, Assignment, Principal	9,450	'
Convertible Promissory Note, Accrued Interest	23,310	15,986
Convertible Promissory Note, Principal After Assignment	$240,550	'

Notes_and_Loans_Payable_Debt_C

Notes and Loans Payable: Debt Conversions (Details) (USD $)	6 Months Ended
	Jul. 31, 2014
Assignee I	'
Convertible Promissory Note, Conversion, Date	29-Apr-14
Convertible Promissory Note, Conversion, Principal	$3,000
Convertible Promissory Note, Conversion, Rate	0.003
Convertible Promissory Note, Conversion, Shares Issued	1,000,000
Assignee III	'
Convertible Promissory Note, Conversion, Date	29-Apr-14
Convertible Promissory Note, Conversion, Principal	3,450
Convertible Promissory Note, Conversion, Rate	0.003
Convertible Promissory Note, Conversion, Shares Issued	1,150,000
Assignee III	'
Convertible Promissory Note, Conversion, Date	27-Jun-14
Convertible Promissory Note, Conversion, Principal	3,000
Convertible Promissory Note, Conversion, Rate	$0.00
Convertible Promissory Note, Conversion, Shares Issued	1,000,000

Notes_and_Loans_Payable_Accrue

Notes and Loans Payable: Accrued Interest (Details) (USD $)	6 Months Ended	12 Months Ended
	Jul. 31, 2014	Jan. 31, 2014
Details	'	'
Convertible Promissory Note, Accrued Interest	$23,310	$15,986

Related_Party_Transactions_Sch1

Related Party Transactions: Schedule of Related Party Transactions (Details) (USD $)	Jul. 31, 2014	Jan. 31, 2014
Details	'	'
Accrued Compensation	$58,250	$58,250
Loans to Company, Notes Payable	22,000	22,000
Loans to Company, Notes Payable-Convertible	69,569	16,991
Total Related Party Loans	91,569	38,991
Total Related Party Transactions	$149,819	$97,241

Related_Party_Transactions_Exe

Related Party Transactions: Executive Employment Agreements (Details) (Michael Borkowski, USD $)	6 Months Ended	12 Months Ended
	Jul. 31, 2014	Jan. 31, 2014
Michael Borkowski	'	'
Related Party Transaction, Date	15-Nov-13	1-Sep-12
Related Party Transaction, Description of Transaction	'2013 Employment Agreement	'2012 Employment Agreement
Related Party Transaction, Term (in years)	1	3
Related Party Transaction, Annual Salary	$18,000	$72,000
Related Party Transaction, Contingent Bonus	'	100,000
Related Party Transaction, Stock Options Granted	'	5,000,000
Related Party Transaction, Stock Options Vested	'	5,000,000
Related Party Transaction, Accrued Compensation	59,000	59,000
Related Party Transaction, Stock Awards	400,000	'
Related Party Transaction, Date of Stock Awards	15-Feb-14	'
Related Party Transaction, Stock Awards Vested Per Period	100,000	'
Related Party Transaction, Stock Awards, Deferred Compensation	640,000	'
Related Party Transaction, Stock Awards, Deferred Compensation, Current Period Expense	480,000	'
Related Party Transaction, Stock Awards, Deferred Compensation, Future Expense	160,000	'
Related Party Transaction, Stock Awards, Deferred Compensation, Future Amort Period (months)	4	'
Related Party Transaction, Prepaid Compensation	$750	$750

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	6 Months Ended	12 Months Ended
	Jul. 31, 2014	Jan. 31, 2014
Eco Science Solutions Intl Inc. Promissory Note	'	'
Related Party Transaction, Date	'	4-Nov-13
Related Party Transaction, Promissory Note, Principal	'	$22,000
Related Party Transaction, Rate	'	5.00%
Related Party Transaction, Terms and Manner of Settlement	'	'due within ninety (90) days of written demand
Related Party Transaction, Accrued Interest	811	265
Eco Science Solutions Intl Inc. Convertible Promissory Note	'	'
Related Party Transaction, Date	31-Jan-14	'
Related Party Transaction, Rate	5.00%	'
Related Party Transaction, Convertible Note, Principal	16,991	'
Related Party Transaction, Convertible Note, Increase in Principal	52,578	'
Related Party Transaction, Term (in years)	2	'
Related Party Transaction, Maturity Date	31-Jan-16	'
Related Party Transaction, Convertible Note, Conversion Rate	'fair market value	'
Related Party Transaction, Convertible Note, Accrued Interest	$869	$0
Domenic Marciano	'	'
Related Party Transaction, Stock Issuance, Date Issued	9-Apr-14	'
Related Party Transaction, Stock Issuance, Shares Issued	19,866,668	'

Related_Party_Transactions_Acc

Related Party Transactions: Accrued Interest (Details) (USD $)	6 Months Ended	12 Months Ended
	Jul. 31, 2014	Jan. 31, 2014
Details	'	'
Related Party Transaction, Accrued Interest	$1,680	$265

Commitments_and_Contingencies_

Commitments and Contingencies (Details) (Eco Science Solutions International, Inc.)	6 Months Ended
	Jul. 31, 2014
Eco Science Solutions International, Inc.	'
License Agreement, Date of Execution	4-Dec-13
License Agreement, Date	4-Nov-13
License Agreement, Term	'in perpetuity
License Agreement, Royalty Due	3.00%
License Agreement, Royalty Base	'Gross Revenues
License Agreement, Royalty Payment Due	'quarterly
License Agreement, Status of Royalties	'no Gross Revenues have been earned.

Preferred_Stock_Authorized_Sha

Preferred Stock: Authorized Shares (Details) (USD $)	Jul. 31, 2014	Jan. 31, 2014
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, par value	$0.00	$0.00
Preferred Stock, Value	'	'
Preferred stock, shares authorized	50,000,000	'
Preferred stock, par value	$0.00	'

Preferred_Stock_Details

Preferred Stock (Details) (USD $)	0 Months Ended
	Apr. 09, 2014	Dec. 04, 2013
Preferred Stock, Shares	'	'
Issuance of Preferred Stock for Patent License	'	$2,500,000
Conversion of Preferred Shares to Common Shares	-2,500,000	'
Preferred Stock, Value	'	'
Issuance of Preferred Stock for Patent License	'	5,265,000
Conversion of Preferred Shares to Common Shares	-5,265,000	'
Additional Paid in Capital, Preferred	'	'
Issuance of Preferred Stock for Patent License	'	$5,262,500
Conversion of Preferred Shares to Common Shares	-5,262,500	'
Common Stock, Shares	'	'
Conversion of Preferred Shares to Common Shares	25,000,000	'

Preferred_Stock_Terms_of_Conve

Preferred Stock: Terms of Conversion (Details)	Jul. 31, 2014
Details	'
Convertible Preferred Stock, Shares Issued upon Conversion	10

Common_Stock_Details

Common Stock (Details) (USD $)	Jul. 31, 2014	Jan. 31, 2014
Details	'	'
Common Stock, shares authorized	650,000,000	650,000,000
Common Stock, par value	$0.10	$0.10
Common Stock, shares outstanding	28,893,001	443,001

Common_Stock_Recent_Activity_D

Common Stock: Recent Activity (Details) (USD $)	0 Months Ended
	Jul. 15, 2014	Jun. 27, 2014	Apr. 29, 2014
Common Stock, Shares	'	'	'
Conversion of Debt	'	$1,000,000	$1,150,000
Issuance of Restricted Stock Award	100,000	'	'
Common Stock, Value	'	'	'
Conversion of Debt	'	100,000	115,000
Issuance of Restricted Stock Award	100	'	'
Additional Paid In Capital, Common	'	'	'
Conversion of Debt	'	-97,000	-111,550
Issuance of Restricted Stock Award	-9,900	'	'
Deferred Compensation	'	'	'
Issuance of Restricted Stock Award	$160,000	'	'

Warrants_and_Options_Details

Warrants and Options (Details) (USD $)	6 Months Ended	12 Months Ended
	Jul. 31, 2014	Jan. 31, 2014
2012 Employee Stock Option Plan	'	'
ESOP Options Granted, Shares	6,500,000	'
ESOP Options Granted, Value, Method Used	'Black-Scholes	'
ESOP Options Granted, Value Per Share	$0.41	'
ESOP Options Granted, Value, Total	$2,665,000	'
ESOP Options Granted, Value, Amortization Period (in months)	36	'
ESOP Options Granted, Deferred Compensation, Current Period Expense	102,500	2,084,617
ESOP Options Granted, Deferred Compensation, Remaining to be Expensed	$256,250	$358,750
ESOP Grants, Officer	'	'
ESOP Options Granted, Shares	5,000,000	'
ESOP Options Granted, Exercise Price	$0.10	'
ESOP Grants, Consultant	'	'
ESOP Options Granted, Shares	1,500,000	'
ESOP Options Granted, Exercise Price	$0.25	'
ESOP Options Granted, Term (in years)	5	'
ESOP Options Granted, Vesting Term (years)	3	'

Warrants_and_Options_Schedule_2

Warrants and Options: Schedule of Options Outstanding (Details) (USD $)	6 Months Ended
	Jul. 31, 2014
ESOP Options Outstanding, Shares	6,500,000
ESOP Options Outstanding, Exercise Price x Shares	$875,000
ESOP Options Outstanding, Weighted Avg Exercise Price	$0.20
$0.10	'
ESOP Options Outstanding, Shares	5,000,000
ESOP Options Outstanding, Remaining Life (in years)	'3 years 3 months
ESOP Options Outstanding, Exercise Price x Shares	500,000
ESOP Options Outstanding, Weighted Avg Exercise Price	$0.10
$0.25	'
ESOP Options Outstanding, Shares	1,500,000
ESOP Options Outstanding, Remaining Life (in years)	'3 years 3 months
ESOP Options Outstanding, Exercise Price x Shares	$375,000
ESOP Options Outstanding, Weighted Avg Exercise Price	$0.25

Warrants_and_Options_Schedule_3

Warrants and Options: Schedule of Options Activity (Details) (Employee Stock Option, USD $)	Jul. 31, 2014
Employee Stock Option	'
ESOP Options, Beginning	6,500,000
ESOP Options, Beginning, Weighted Avg Exercise Price	$0.20
ESOP Options, Ending	6,500,000
ESOP Options, Ending, Weighted Avg Exercise Price	$0.20

Restricted_Stock_Awards_Detail

Restricted Stock Awards (Details) (USD $)	6 Months Ended
	Jul. 31, 2014
Restricted Stock Award, Deferred Compensation	$640,000
Restricted Stock Award, Deferred Compensation, Current Period Expense	480,000
Restricted Stock Award, Deferred Compensation, Future Expense	160,000
Michael Borkowski	'
Restricted Stock Award, Date of Award	15-Feb-14
Restricted Stock Award, Total Units Awarded (Common Stock)	400,000
Restricted Stock Award, Price Per Unit	0.001
Restricted Stock Award, Value	640,000
Restricted Stock Award, Units Vested Per Period	100,000
Restricted Stock Award, Deferred Compensation	640,000
Restricted Stock Award, Deferred Compensation, Current Period Expense	480,000
Restricted Stock Award, Units Vested, Total	300,000
Restricted Stock Award, Deferred Compensation, Future Expense	160,000
Restricted Stock Award, Deferred Compensation, Future Expense, Period (in Months)	$4

Restricted_Stock_Awards_Schedu1

Restricted Stock Awards: Schedule of RSU Activity (Details) (Restricted Stock Units (RSUs), USD $)	6 Months Ended
	Jul. 31, 2014
Restricted Stock Units (RSUs)	'
Restricted Stock Units, Awarded	400,000
Restricted Stock Units, Weighted Average Exercise Price, Awards	$0.00
Restricted Stock Units, Vested in Period	-300,000
Restricted Stock Units, Vested in Period, Weighted Average Exercise Price	$0.00
Restricted Stock Units, Ending	100,000
Restricted Stock Units, Ending, Weighted Average Exercise Price	$0.00

Restricted_Stock_Awards_Deferr

Restricted Stock Awards: Deferred Compensation (Details) (USD $)	6 Months Ended
	Jul. 31, 2014
Details	'
Restricted Stock Award, Deferred Compensation	$640,000
Restricted Stock Award, Deferred Compensation, Current Period Expense	480,000
Restricted Stock Award, Deferred Compensation, Future Expense	$160,000

Income_Taxes_Schedule_of_Effec1

Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Details) (USD $)	0 Months Ended	6 Months Ended
	Jan. 31, 2014	Jul. 31, 2014
Details	'	'
Continuing Operations	($7,452,402)	($631,844)
Discontinued Operations	-384,505	'
Total Income (Loss) Before Taxes	-7,836,907	-631,844
Statutory Rate	34.00%	34.00%
Computed Expected Tax Payable (Recovery)	-2,664,400	-214,800
Non-Deductible Expenses	1,000	'
Change in Valuation Allowance	$2,663,400	$214,800

Income_Taxes_Schedule_of_Compo1

Income Taxes: Schedule of Components of Income Tax Expense (Benefit) (Details) (USD $)	Jul. 31, 2014	Jan. 31, 2013
Details	'	'
Net Operating Loss Carryforward-Continuing Operations	$2,834,800	$2,620,000
Less: Valuation Allowance	-2,834,800	-2,620,000
Net Operating Loss Carryforward-Discontinued Operations	263,700	263,700
Less Valuation Allowance	($263,700)	($263,700)